Acquisition of a Q-Exactive Plus mass spectrometer.

购买 Q-Exactive Plus 质谱仪。

基本信息

  • 批准号:
    8826551
  • 负责人:
  • 金额:
    $ 60万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-02-10 至 2017-02-09
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The aim of this proposal is to request funding for a new state-of-the-art nano UPLC Q-Exactive Plus mass spectrometer from Thermo Scientific, which we plan to integrate into the Proteome Exploration Laboratory (PEL) of the Beckman Institute at the California Institute of Technology (Caltech) to replace our existing Orbitrap Classic mass spectrometer, which is now reaching the maximum expected lifetime and thus, Thermo is phasing out their support on this instrument. We request funding because technological limitations of our current instruments are no longer meeting methodological demands of the increasing number of users, hampering the progress of NIH-funded projects in the laboratories of our collaborators. Due to technological innovations, the Orbitrap Classic can effectively no longer compete with current state-of-the-art technology as a result of the tremendous instrumentation developments during the past years; and is therefore hindering our advancement in the field of proteomics. The Q-Exactive Plus also offers unique measurement capabilities due to its quadrupole filter rather than an ion trap, which will enable many projects t the PEL that we can currently not carry out. The PEL was established in 2007 and is the only resource center at Caltech where mass spectrometry-based proteomic analyses can be performed. The PEL was initially established to primarily collaborate with students and postdoctoral fellows of the Caltech community to develop new methods and advance their proteomics-related research. Due to its commitment to excellence, the PEL is frequently able to analyze difficult samples that typical facilities may not be successful with. As a consequence, the PEL has developed into a center that is also sought out by other researchers as well, local and state-wide. The overwhelming success of our proteomics setup has steadily increased the demand at the PEL and continues to increase further. The main long-term objective of the PEL is to enable the in-depth elucidation and quantification of proteomes, subproteomes and individual proteins to gain fundamental insights into biological regulatory processes. A common experimental paradigm is to monitor global protein changes that occur after either treating cells with drugs or natural ligands; or subjecting them to an environmental or genetic perturbation. A Q-Exactive Plus mass spectrometer coupled with the EASY nano UPLC system, working in concert with our existing bioinformatics pipeline, will play a vital role in advancing projects tha span a broad range of fundamental (developmental processes) and applied studies (cancer, bacterial infections). Fundamental insights into any of these areas will help prevent and/or cure diseases that have previously been considered incurable.
 描述(申请人提供):该提案的目的是为Thermo Scientific的新型最先进的纳米UPLC Q-Exactive Plus质谱仪申请资金,我们计划将其整合到加州理工学院(Caltech)贝克曼研究所的蛋白质组探索实验室(PEL)中,以取代我们现有的Orbitrap Classic质谱仪,现在达到了最大预期寿命,因此,Thermo正在逐步停止对该仪器的支持。我们要求资金,因为我们目前的仪器的技术限制不再满足越来越多的用户的方法学需求,阻碍了NIH资助的项目在我们合作者的实验室的进展。由于技术创新,Orbitrap Classic在过去几年中由于仪器的巨大发展而不再能够有效地与当前最先进的技术竞争;因此阻碍了我们在蛋白质组学领域的进步。Q-Exactive Plus还提供了独特的测量功能,因为它的四极滤波器而不是离子阱,这将使我们目前无法执行的许多项目能够在PEL上进行。PEL成立于2007年,是加州理工学院唯一的资源中心,可以进行基于质谱的蛋白质组学分析。PEL最初成立的主要目的是与加州理工学院社区的学生和博士后研究员合作,开发新方法并推进他们的蛋白质组学相关研究。由于其对卓越的承诺,PEL经常能够分析典型设施可能无法成功的困难样品。因此,PEL已经发展成为一个中心,也是由其他研究人员以及,地方和国家范围内寻求。我们蛋白质组学设置的巨大成功稳步增加了PEL的需求,并将继续进一步增加。PEL的主要长期目标是能够深入阐明和定量蛋白质组,亚蛋白质组和单个蛋白质,以获得对生物调控过程的基本见解。一种常见的实验范式是监测用药物或天然配体处理细胞后发生的整体蛋白质变化;或使它们受到环境或遗传干扰。Q-Exactive Plus质谱仪与EASY nano UPLC系统相结合,与我们现有的生物信息学管道协同工作,将在推进涵盖广泛的基础(开发过程)和应用研究(癌症,细菌感染)的项目中发挥至关重要的作用。对这些领域的基本见解将有助于预防和/或治愈以前被认为无法治愈的疾病。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interrogating marine virus-host interactions and elemental transfer with BONCAT and nanoSIMS-based methods.
使用 BONCAT 和基于 nanoSIMS 的方法研究海洋病毒与宿主的相互作用和元素转移。
  • DOI:
    10.1111/1462-2920.13996
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Pasulka,AlexisL;Thamatrakoln,Kimberlee;Kopf,SebastianH;Guan,Yunbin;Poulos,Bonnie;Moradian,Annie;Sweredoski,MichaelJ;Hess,Sonja;Sullivan,MathewB;Bidle,KayD;Orphan,VictoriaJ
  • 通讯作者:
    Orphan,VictoriaJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sonja Hess其他文献

Sonja Hess的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sonja Hess', 18)}}的其他基金

Purchase of a nanoLC-QTRAP Mass Spectrometer for Targeted Proteomics Studies
购买 nanoLC-QTRAP 质谱仪用于靶向蛋白质组学研究
  • 批准号:
    8447770
  • 财政年份:
    2013
  • 资助金额:
    $ 60万
  • 项目类别:
Purchase of a Liquid Chromatograph-Orbitrap VELOS mass spectrometer
购买液相色谱-Orbitrap VELOS 质谱仪
  • 批准号:
    8052978
  • 财政年份:
    2011
  • 资助金额:
    $ 60万
  • 项目类别:
Mass spectrometric investigation of biomolecules and dru
生物分子和药物的质谱研究
  • 批准号:
    7153595
  • 财政年份:
  • 资助金额:
    $ 60万
  • 项目类别:
Mass spectrometric investigation of biomolecules and dru
生物分子和药物的质谱研究
  • 批准号:
    7337596
  • 财政年份:
  • 资助金额:
    $ 60万
  • 项目类别:

相似海外基金

Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
  • 批准号:
    10574286
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
  • 批准号:
    10649771
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
  • 批准号:
    10644889
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
  • 批准号:
    MR/X031993/1
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
  • 批准号:
    EP/X014479/1
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
  • 批准号:
    10588846
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
  • 批准号:
    10674221
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
  • 批准号:
    10073241
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了